142001-63-6 Usage
General Description
Saredutant is a chemical compound that acts as a selective antagonist of the neurokinin-2 receptor, which is involved in the regulation of various physiological processes including stress and anxiety responses, mood, and cognitive functions. It has been studied as a potential treatment for mood and anxiety disorders, and has shown promising results in preclinical and clinical trials. Saredutant is believed to work by blocking the actions of substance P, a neuropeptide that plays a role in the modulation of stress and anxiety responses. While more research is needed to fully understand the mechanisms and potential therapeutic uses of saredutant, it represents a promising avenue for the development of new treatments for psychiatric conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 142001-63-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,2,0,0 and 1 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 142001-63:
(8*1)+(7*4)+(6*2)+(5*0)+(4*0)+(3*1)+(2*6)+(1*3)=66
66 % 10 = 6
So 142001-63-6 is a valid CAS Registry Number.
InChI:InChI=1/C31H35Cl2N3O2/c1-23(37)34-31(27-11-7-4-8-12-27)16-19-36(20-17-31)18-15-26(25-13-14-28(32)29(33)21-25)22-35(2)30(38)24-9-5-3-6-10-24/h3-14,21,26H,15-20,22H2,1-2H3,(H,34,37)/t26-/m1/s1
142001-63-6Relevant articles and documents
4-Amino-2-(aryl)-butylbenzamides and their conformationally constrained analogues. Potent antagonists of the human neurokinin-2 (NK2) receptor
MacKenzie, A. Roderick,Marchington, Allan P.,Middleton, Donald S.,Newman, Sandra D.,Selway, Christopher N.,Terrett, Nicholas K.
, p. 2211 - 2215 (2007/10/03)
A library, evaluating a range of piperazines, piperidines and acyclic amines, as replacements for the 4-hydroxy-4-phenylpiperidine moiety in lead (1b) was prepared. These efforts identified the 4-((N)-benzimidazolone)piperidine analogue (2a) which was further optimised using classical single-compound synthesis to yield the 3-((N)-morpholino)azetidine (2j). Conformationally constrained analogues of (2j), generally offered no potency advantage in this particular series.
Process for the preparation of an optically pure aminoalcohol
-
, (2008/06/13)
A process is described for the preparation of (+)-2-(3,4-dichlorophenyl)-4-hydroxybutylamine (I) by reaction of 3,4-dichlorophenylacetonitrile (II) with an alkali metal halogenoacetate, treatment of the 3-cyano-3-(3,4-dichlorophenyl)propionic acid (III) w